The Trustees of the University of Pennsylvania;Inovio Pharmaceuticals, Inc.
发明人:
Weiner, David,Lang, Krystle,Yan, Jian,Draghia-Akli, Ruxandra,Khan, Amir
申请号：
AU2020213308
公开号：
AU2020213308A1
申请日:
2020.08.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020213308A120200827.pdf#####ABSTRACT Improved anti-HCV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HCV genotype la, 5 including for example, NS4B, NS5A and NS5B. Pharmaceutical composition, recombinant vaccines comprising and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against HCV are disclosed.
